Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients
Authors:
- Daniel Cosmin CarageaDaniel Cosmin Caragea
- Lidia BoldeanuLBLidia Boldeanu
- Mohamed-Zakaria AssaniMohamed-Zakaria Assani
- Mariana-Emilia CarageaMCMariana-Emilia Caragea
- Alexandra-Ștefania Stroe-IonescuASAlexandra-Ștefania Stroe-Ionescu
- Romeo PopaRPRomeo Popa
- Daniela-Teodora MariaDMDaniela-Teodora Maria
- Vlad PădureanuVlad Pădureanu
- Cristin Constantin VereCVCristin Constantin Vere
- Mihail Virgil BoldeanuMihail Virgil Boldeanu
Open Access
- 1 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10670
Abstract
We compared oxidative markers and their links to inflammation in diabetic nephropathy and hemodialysis to identify independent determinants. We studied 180 adults, 90 patients with type 2 diabetes and diabetic nephropathy and 90 patients on hemodialysis. We measured serum advanced oxidation protein products (AOPP) and thiobarbituric acid reactive substances (TBARS) by enzyme-linked immunosorbent assay (ELISA). Partial correlations were adjusted for age, sex, and albumin with false discovery rate (FDR) control. Principal component analysis (PCA) summarized inflammatory indices and linear models tested predictors of AOPP and TBARS. Oxidative damage was higher in hemodialysis, with AOPP median 25.80 versus 5.06 and TBARS 8.49 versus 1.89, p less than 0.0001. C reactive protein (CRP) and mean corpuscular volume-to-lymphocyte ratio (MCVL) were higher in patients ongoing hemodialysis; systemic immune-inflammation index (SII) was higher in diabetic nephropathy. PCA yielded a dominant inflammation axis in both cohorts, 74.73 percent in hemodialysis and 85.20 percent in diabetic nephropathy. In regression, creatinine (β = 2.47, p = 0.026) predicted AOPP in hemodialysis. Dialysis vintage inversely predicted TBARS, β = −0.2305, p = 0.0209. In diabetic nephropathy, the PCA inflammation score predicted AOPP, β = 1.134, p = 0.0003. Protein oxidation tracked systemic inflammation in diabetic nephropathy, but not in hemodialysis. AOPP outperformed TBARS as an inflammatory partner and a practical monitoring candidate in diabetic kidney disease. Prospective studies should test for prognostic value and therapy sensitivity.Keywords
Funding Information
- University of Medicine and Pharmacy of Craiova, Romania
This publication has 45 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancerJournal of Cachexia, Sarcopenia and Muscle, 2023
- Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM interventionRenal Failure, 2023
- Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of BiomarkersOxidative Medicine and Cellular Longevity, 2020
- Diabetic nephropathy: Is there a role for oxidative stress?Free Radical Biology and Medicine, 2018
- Oxidative Stress in Hemodialysis Patients: A Review of the LiteratureOxidative Medicine and Cellular Longevity, 2017
- Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expressionScientific Reports, 2016
- Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney DiseaseOxidative Medicine and Cellular Longevity, 2013
- Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKDAmerican Journal of Kidney Diseases, 2006
- Correlates of Markers of Oxidative Status in the General PopulationAmerican Journal of Epidemiology, 2001